Business Wire

Vifor Pharma comments on market speculations

Share

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Due to current market speculations, Vifor Pharma Group states the following:

Vifor Pharma Group systematically reviews options that can strengthen its market position and/or accelerate the growth of the company both organically and through partnerships and acquisitions. Vifor Pharma is therefore regularly in discussions with other market participants and does not comment on them.

About Vifor Pharma Group
Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

For more information, please visit viforpharma.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Relations
Nathalie Ponnier
Global Head Corporate Communications
+41 79 957 96 73
media@viforpharma.com

Investor Rations
Julien Vignot
Head of Investor Relations
+41 58 851 66 90
investors@viforpharma.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rimini Street Korea Ranked 8 th in Nation by Best Workplaces™ Korea and Awarded Best Workplaces™ for Parents and Most Respected CEO22.2.2024 23:46:00 CET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products, and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, proudly announces its achievement of ranking 8th in the nation as Best Workplaces™ in Korea, along with four additional Great Place to Work® 2024 Korea awards. This recognition builds on Rimini Street’s multiple culture awards and certifications across the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222652878/en/ Rimini Street Korea Ranked 8th in Nation by Best Workplaces™ Korea and Awarded Best Workplaces™ for Parents and Most Respected CEO (Photo: Business Wire) Great Place to Work® is the global authority on workplace culture, employee experience, and leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation. Best Workplaces™ awards are gr

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in the Phase 2 NEUROFUSE Study, Reinforcing Previously Announced Proof of Concept 12-Week Data22.2.2024 22:44:00 CET | Press release

Neuraptive Therapeutics, Inc., a pioneer in nerve repair and regeneration, is proud to announce new 24-week data from the ongoing NEUROFUSE Study for NTX-001, further solidifying the product's status following the previously announced proof of concept results based on the 12-week data in January 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222942067/en/ Evan L. Tzanis, COO and EVP Head of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire) The latest data from the multicenter, randomized, evaluator-blinded, Phase 2a NEUROFUSE Study underscores NTX-001’s sustained safety and efficacy as an adjunct treatment for transected peripheral nerves. At the 24-week mark, NTX-001 continues to demonstrate an encouraging safety profile, with lower treatment-emergent adverse event rates than the standard of care. Regarding efficacy, NTX-001 showed a statistically significant improvement in hand function and symptomatology

Datasite Acquires Zurich-based Sherpany22.2.2024 22:00:00 CET | Press release

Datasite®, a leading SaaS platform used by enterprises globally to execute complex, strategic projects, today announced that it has acquired Sherpany®, a Zurich-based board reporting and meeting management software provider. Terms of the agreement are not being disclosed and the transaction is expected to close in Q1 2024, subject to closing conditions. “Datasite is committed to delivering products that enable professionals to execute complex, strategic projects,” said Rusty Wiley, President & Chief Executive Officer of Datasite. “The acquisition of Sherpany extends our product suite with advanced functionality that facilitates board collaboration and meeting management, further enhancing organizational productivity. We look forward to integrating these capabilities into the Datasite platform, adding significant value for our customers.” Founded in 2011 and with offices across Europe, Sherpany’s software allows professionals to increase productivity by streamlining both board and gener

Announcing Moveworks.global: Where the Future of Enterprise AI Comes to Life22.2.2024 21:00:00 CET | Press release

Moveworks, the leading AI copilot platform for the enterprise, today announced registration for its annual Moveworks.global conference is now open. The event will take place on April 23, 2024, and will be held both virtually and in-person in San Jose, CA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222535446/en/ In an era where artificial intelligence is not just an advantage but a necessity, Moveworks.global is the must-attend event for industry leaders, developers, and forward-thinkers eager to explore the transformative power of generative AI in business. This event serves as a dynamic platform for participants to engage with the brightest minds in the industry. With past speakers from world-renowned companies like OpenAI, Salesforce, Honeywell, and more, attendees will learn firsthand how best-in-class organizations are leveraging generative AI to foster unprecedented levels of business agility. From global corpora

Data Roaming Without Worries, Now in Every App : eSIM Innovator 1GLOBAL gives FinTech its Own Roaming Service22.2.2024 18:39:00 CET | Press release

The range of industries adopting 1GLOBAL’s innovative services continues to grow as more than 30 million European customers will be soon avoiding roaming charges in over 160 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222033843/en/ Data Roaming Without Worries, Now in Every App: eSIM Innovator 1GLOBAL gives FinTech its Own Roaming Service. (Graphic: Business Wire) By fully integrating the 1GLOBAL API, global fintech Revolut now offers its customers simple, fast access to 1GLOBAL's low-cost global mobile network. Once activated by the user, an embedded SIM (eSIM) is generated for the mobile device. "Without having to leave the Revolut app, users can install an eSIM within one minute,” said Hakan Koç, Founder and CEO of 1GLOBAL. “This is why players from a wide range of industries such as travel, insurance, fintech, airlines, VIP logistics and more are all coming to us to increase the range of services they of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye